SCHEDULE: Woodline Partners Reports 1.6% Stake in Outset Medical

Woodline Partners LP has disclosed a beneficial ownership of 1.6% in Outset Medical, Inc., holding 292,437 shares as of March 31, 2026.

Summary

• Woodline Partners LP, acting as the investment adviser to Woodline Master Fund LP, has filed a Schedule 13G, indicating its beneficial ownership of Outset Medical, Inc. common stock.
• The filing reports that Woodline Partners LP has sole voting power and sole dispositive power over 292,437 shares of Outset Medical's common stock.
• This holding represents 1.6% of the total outstanding shares of Outset Medical, Inc. common stock.
• The total number of outstanding shares used for this calculation was 18,311,626 as of February 10, 2026, based on the Company's Annual Report on Form 10-K filed on February 13, 2026.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it is a standard disclosure of beneficial ownership by an investment firm and does not provide operational or financial performance updates for Outset Medical, Inc.

Positives

• Woodline Partners LP has established a significant stake, indicating confidence in Outset Medical's future prospects.
• The filing is a routine disclosure, suggesting no immediate changes in control or unusual activity.

Negatives

• The filing does not contain any negative financial information or operational concerns.
• The ownership stake is passive, as indicated by the certification that shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control.

Risks

• The filing does not explicitly mention any current issues or potential future challenges for Outset Medical, Inc.

Future Outlook

The filing does not contain forward-looking statements or guidance from Outset Medical, Inc. It is a disclosure of beneficial ownership by an investment entity.

Industry Context

StockSavvy.ai notes that Schedule 13G filings are common for institutional investors accumulating stakes in publicly traded companies. This filing indicates Woodline Partners LP's investment activity in the medical device sector, specifically in companies focused on innovative healthcare solutions.

Stakeholder Impact

• Shareholders: The filing provides transparency regarding significant institutional ownership, which can be a factor in market perception.
• Management: The disclosure confirms an investment by Woodline Partners LP, which may be noted by the company's board and management.

Next Steps

• Woodline Partners LP will continue to hold its shares in Outset Medical, Inc. in the ordinary course of business.

Key Dates

Keywords

Outset Medical, Schedule 13G, Woodline Partners LP, beneficial ownership, common stock, investment adviser, SEC filing